de Tribolet N - Search Results

1

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY. Saas P, et al. Among authors: de tribolet n. J Clin Invest. 1997 Mar 15;99(6):1173-8. doi: 10.1172/JCI119273. J Clin Invest. 1997. PMID: 9077524 Free PMC article.

2

T-cell immune responses in the brain and their relevance for cerebral malignancies.

Walker PR, Calzascia T, de Tribolet N, Dietrich PY. Walker PR, et al. Among authors: de tribolet n. Brain Res Brain Res Rev. 2003 May;42(2):97-122. doi: 10.1016/s0165-0173(03)00141-3. Brain Res Brain Res Rev. 2003. PMID: 12738053 Review.

3

Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.

Perrin G, Schnuriger V, Quiquerez AL, Saas P, Pannetier C, de Tribolet N, Tiercy JM, Aubry JP, Dietrich PY, Walker PR. Perrin G, et al. Among authors: de tribolet n. Int Immunol. 1999 Aug;11(8):1337-50. doi: 10.1093/intimm/11.8.1337. Int Immunol. 1999. PMID: 10421791

4

The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells.

Walker PR, Calzascia T, Schnuriger V, Scamuffa N, Saas P, de Tribolet N, Dietrich PY. Walker PR, et al. Among authors: de tribolet n. J Immunol. 2000 Sep 15;165(6):3128-35. doi: 10.4049/jimmunol.165.6.3128. J Immunol. 2000. PMID: 10975826

5

Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells.

Masson F, Calzascia T, Di Berardino-Besson W, de Tribolet N, Dietrich PY, Walker PR. Masson F, et al. Among authors: de tribolet n. J Immunol. 2007 Jul 15;179(2):845-53. doi: 10.4049/jimmunol.179.2.845. J Immunol. 2007. PMID: 17617575

6

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

Calzascia T, Di Berardino-Besson W, Wilmotte R, Masson F, de Tribolet N, Dietrich PY, Walker PR. Calzascia T, et al. Among authors: de tribolet n. J Immunol. 2003 Sep 1;171(5):2187-91. doi: 10.4049/jimmunol.171.5.2187. J Immunol. 2003. PMID: 12928361

7

Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.

Desbaillets I, Tada M, de Tribolet N, Diserens AC, Hamou MF, Van Meir EG. Desbaillets I, et al. Among authors: de tribolet n. Int J Cancer. 1994 Jul 15;58(2):240-7. doi: 10.1002/ijc.2910580216. Int J Cancer. 1994. PMID: 7517920

8

Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.

Ishii N, Sawamura Y, Tada M, Daub DM, Janzer RC, Meagher-Villemure M, de Tribolet N, Van Meir EG. Ishii N, et al. Among authors: de tribolet n. Int J Cancer. 1998 Jun 10;76(6):797-800. doi: 10.1002/(sici)1097-0215(19980610)76:6<797::aid-ijc5>3.0.co;2-t. Int J Cancer. 1998. PMID: 9626343

9

Immunobiology of gliomas: new perspectives for therapy.

Dietrich PY, Walker PR, Saas P, de Tribolet N. Dietrich PY, et al. Among authors: de tribolet n. Ann N Y Acad Sci. 1997 Sep 17;824:124-40. doi: 10.1111/j.1749-6632.1997.tb46215.x. Ann N Y Acad Sci. 1997. PMID: 9382437 Review. No abstract available.

10

Survivin in brain tumors: an attractive target for immunotherapy.

Katoh M, Wilmotte R, Belkouch MC, de Tribolet N, Pizzolato G, Dietrich PY. Katoh M, et al. Among authors: de tribolet n. J Neurooncol. 2003 Aug-Sep;64(1-2):71-6. doi: 10.1007/BF02700022. J Neurooncol. 2003. PMID: 12952288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters